The thread of life Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : The thread of life

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Extra Pale who wrote (47)	11/3/2000 1:14:52 PM
From: scaram(o)uche	Read Replies (2) of 1336

Extra: These are biobucks. They're undoubtedly graduated milestone payments. Initial amounts rec'd will not be large. Moreover, the $$ per antigen are not particularly impressive (less than $20 million in milestones through marketing approval). OTOH, I would predict that a number of the initial milestone payments are all but in the pocket, and that each will trigger PR of interest. Nice deal, but..... as always, one should consider it as a collaboration, looking at potential royalty revenues. Looking deeper, what does this deal tell us? We know that GZMO is as good as anyone at differential expression (SAGE). We know that they're forward-thinking when it comes to antigen selection (Rosenberg and melanoma is a good example) and vaccine format (the two dendritic cell presentations). The take home lesson is, therefore, that Purdue has foresight. Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next